Prospective evaluation of cetuximab-mediated antibody-dependent cell cytotoxicity (ADCC) in metastatic colorectal cancer patients predicts treatment efficacy.
Trotta, A. M., Ottaiano, A., Romano, C., Nasti, G., Nappi, A., De Divitiis, C., Napolitano, M., Zanotta, S., Casaretti, R., D'Alterio, C., Avallone, A., Califano, D., Iaffaioli, R. V., Scala, S.Language:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-15-0184
Date:
January, 2016
File:
PDF, 1.26 MB
english, 2016